Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
SARS-CoV-2 immunity and vaccine strategies in people with HIV.
Mullender C, da Costa KAS, Alrubayyi A, Pett SL, Peppa D. Mullender C, et al. Among authors: alrubayyi a. Oxf Open Immunol. 2022 Aug 17;3(1):iqac005. doi: 10.1093/oxfimm/iqac005. eCollection 2022. Oxf Open Immunol. 2022. PMID: 36846557 Free PMC article. Review.
Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report.
Gupta RK, Peppa D, Hill AL, Gálvez C, Salgado M, Pace M, McCoy LE, Griffith SA, Thornhill J, Alrubayyi A, Huyveneers LEP, Nastouli E, Grant P, Edwards SG, Innes AJ, Frater J, Nijhuis M, Wensing AMJ, Martinez-Picado J, Olavarria E. Gupta RK, et al. Among authors: alrubayyi a. Lancet HIV. 2020 May;7(5):e340-e347. doi: 10.1016/S2352-3018(20)30069-2. Epub 2020 Mar 10. Lancet HIV. 2020. PMID: 32169158 Free PMC article.
Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV.
Alrubayyi A, Gea-Mallorquí E, Touizer E, Hameiri-Bowen D, Kopycinski J, Charlton B, Fisher-Pearson N, Muir L, Rosa A, Roustan C, Earl C, Cherepanov P, Pellegrino P, Waters L, Burns F, Kinloch S, Dong T, Dorrell L, Rowland-Jones S, McCoy LE, Peppa D. Alrubayyi A, et al. bioRxiv [Preprint]. 2021 Feb 16:2021.02.15.431215. doi: 10.1101/2021.02.15.431215. bioRxiv. 2021. Update in: Nat Commun. 2021 Oct 5;12(1):5839. doi: 10.1038/s41467-021-26137-7 PMID: 33619489 Free PMC article. Updated. Preprint.
Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIV.
Touizer E, Alrubayyi A, Rees-Spear C, Fisher-Pearson N, Griffith SA, Muir L, Pellegrino P, Waters L, Burns F, Kinloch S, Rowland-Jones S, Gupta RK, Gilson R, Peppa D, McCoy LE. Touizer E, et al. Among authors: alrubayyi a. Lancet HIV. 2021 Jun;8(6):e317-e318. doi: 10.1016/S2352-3018(21)00099-0. Lancet HIV. 2021. PMID: 34087093 Free PMC article. No abstract available.
The role and uses of antibodies in COVID-19 infections: a living review.
Scourfield DO, Reed SG, Quastel M, Alderson J, Bart VMT, Teijeira Crespo A, Jones R, Pring E, Richter FC; Oxford-Cardiff COVID-19 Literature Consortium; Burnell SEA. Scourfield DO, et al. Oxf Open Immunol. 2021 Jan 28;2(1):iqab003. doi: 10.1093/oxfimm/iqab003. eCollection 2021. Oxf Open Immunol. 2021. PMID: 34192270 Free PMC article. Review.
Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV.
Alrubayyi A, Gea-Mallorquí E, Touizer E, Hameiri-Bowen D, Kopycinski J, Charlton B, Fisher-Pearson N, Muir L, Rosa A, Roustan C, Earl C, Cherepanov P, Pellegrino P, Waters L, Burns F, Kinloch S, Dong T, Dorrell L, Rowland-Jones S, McCoy LE, Peppa D. Alrubayyi A, et al. Nat Commun. 2021 Oct 5;12(1):5839. doi: 10.1038/s41467-021-26137-7. Nat Commun. 2021. PMID: 34611163 Free PMC article.
34 results